NCT05063552 2026-06-03Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck CancersNational Cancer Institute (NCI)Phase 2/3 Active not recruiting430 enrolled